| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Forty young men were inoculated with live, attenuated VEE virus vaccine, and as evidenced by a significant increase in hemagglutination-inhibiting antibody titers, all were infected. However, viremia was demonstrated in only 13. The level of viremia was low, varied with time, and occurred between 60 hours and 12 days after vaccination. All subjects were evaluated closely from clinical, laboratory, virologic, and serologic standpoints. Some degree of reaction was seen in 37.5% of these persons, 10% of them having a 3+ reaction, of a possible 4+. Viremia was demonstrated in 32.5%. Transient electrocardiographic abnormalities were noted in 47.5%, and 40% had transient leukopenia. Eight men followed with daily electroencephalographic tracings demonstrated no significant change subsequent to vaccination. There was no consistent positive or negative correlation between any of these responses or combination of responses.
* These studies were conducted in conjunction with a program for the development and testing of vaccines and for the therapy of acute infection. The investigations were supervised by the Commission on Epidemiological Survey of the Armed Forces Epidemiological Board. Requests for reprints should be addressed the Office of the Commanding Officer, United States Army Medical Unit, Fort Detrick, Frederick, Maryland 21701.
Present address: 1209 St. Paul Street, Baltimore, Maryland 21202.
Present address: Children's Service, Massachusetts General Hospital, 32 Fruit Street, Boston, Massachusetts 02114.
This article has been cited by other articles:
|
|
 |
|
  S. Atasheva, N. Garmashova, I. Frolov, and E. Frolova Venezuelan Equine Encephalitis Virus Capsid Protein Inhibits Nuclear Import in Mammalian but Not in Mosquito Cells J. Virol., April 15, 2008; 82(8): 4028 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Rosas, S. Paessler, H. Ni, and N. Osterrieder Protection of Mice by Equine Herpesvirus Type 1 Based Experimental Vaccine against Lethal Venezuelan Equine Encephalitis Virus Infection in the Absence of Neutralizing Antibodies Am J Trop Med Hyg, January 1, 2008; 78(1): 83 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Garmashova, S. Atasheva, W. Kang, S. C. Weaver, E. Frolova, and I. Frolov Analysis of Venezuelan Equine Encephalitis Virus Capsid Protein Function in the Inhibition of Cellular Transcription J. Virol., December 15, 2007; 81(24): 13552 - 13565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. NI, N. E. YUN, M. A. ZACKS, S. C. WEAVER, R. B. TESH, A. P. T. DA ROSA, A. M. POWERS, I. FROLOV, and S. PAESSLER RECOMBINANT ALPHAVIRUSES ARE SAFE AND USEFUL SEROLOGICAL DIAGNOSTIC TOOLS Am J Trop Med Hyg, April 1, 2007; 76(4): 774 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Grabenstein, P. R. Pittman, J. T. Greenwood, and R. J.M. Engler Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects Epidemiol. Rev., August 1, 2006; 28(1): 3 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Paessler, H. Ni, O. Petrakova, R. Z. Fayzulin, N. Yun, M. Anishchenko, S. C. Weaver, and I. Frolov Replication and Clearance of Venezuelan Equine Encephalitis Virus from the Brains of Animals Vaccinated with Chimeric SIN/VEE Viruses J. Virol., March 15, 2006; 80(6): 2784 - 2796. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
